A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, CLINICAL STUDY TO COMPARE THE SAFETY AND EFFICACY OF IDP-126 GEL TO EPIDUO FORTE GEL (0.3% ADAPALENE/2.5%BPO), IN THE TREATMENT OF ACNE VULGARIS
- Registry ID
- V01-126A-202
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Phase
- PHASE2
- Study type
- INTERVENTIONAL
- Sponsor
- BAUSCH HEALTH AMERICAS, INC.
- Start date
- 2021-06-22
- Last update
- 2021-04-27
Conditions
Related clinical trials
- A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, 2 ARM, PARALLEL GROUP STUDY COMPARING THE SAFETY AND EFFICACY OF IDP-120 GEL AND IDP-120 VEHICLE GEL IN THE TREATMENT OF ACNE VULGARIS
- A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, 2 ARM, PARALLEL GROUP STUDY COMPARING THE SAFETY AND EFFICACY OF IDP-120 GEL AND IDP-120 VEHICLE GEL IN THE TREATMENT OF ACNE VULGARIS
- AN OPEN-LABEL SAFETY AND PHARMACOKINETIC STUDY OF OLUMACOSTAT GLASARETIL GEL APPLIED UNDER MAXIMUM USE CONDITIONS IN PATIENTS WITH ACNE VULGARIS
- A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, 2 ARM, PARALLEL GROUP STUDY COMPARING THE SAFETY AND EFFICACY OF IDP-123 LOTION AND IDP-123 VEHICLE LOTION IN THE TREATMENT OF ACNE VULGARIS
- A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, 2 ARM, PARALLEL GROUP STUDY COMPARING THE SAFETY AND EFFICACY OF IDP-123 LOTION AND IDP-123 VEHICLE LOTION IN THE TREATMENT OF ACNE VULGARIS
- A PHASE 2, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, DOSE-RANGING STUDY OF DRM01B TOPICAL GEL IN SUBJECTS WITH ACNE VULGARIS
View on source registry